Checking lung screening participants for COPD using breath tests and scans
Looks at how common COPD is among adults getting lung cancer screening scans.
Key facts
- Who runs it
- Temple University
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Registry title
- Temple Health Chest Initiative (THCI 2.0)
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 28 Feb 2025
- Planned end
- 30 Jun 2026
- Type of study
- Observational
- Treatments tested
- Determine COPD prevalence utilizing spirometry along with CT scans and symptom assessments in the THCI lung cancer screening populatio
- Record updated
- 18 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 50 to 80 who are being screened for early lung cancer with a low dose CT scan. It checks how common COPD is in this group.
- Age
- 50 to 80 years old
- Sex
- All sexes can join.
Main reasons for not taking part
- Under 50 or over 80 years old
- Not having lung cancer screening
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- 50 to 80 years old
- Screened for early lung cancer using low dose CT imaging
Who cannot take part
- No lung cancer screening
- Under 50; over 80 years old
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 80 years old?
Where in United States
- Temple University Of the Commonwealth System of Higher EducationPhiladelphia, United StatesContact: Lauren Miller, BSTaking people
About the trial
What the trial wants to find out
Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.
The group in the trial
- Pulmonary function testing
If the patient does have airflow obstruction (any severity) they will be contacted to complete additional questionnaires.
Treatment: Determine COPD prevalence utilizing spirometry along with CT scans and symptom assessments in the THCI lung cancer screening populatio
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Temple Health Chest Initiative (THCI 2.0) - Lung Cancer Screening Project With COPD Detection
- Plain-language title
- Checking lung screening participants for COPD using breath tests and scansGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06933758, who can take part
- Record updated
- 18 April 2025